Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
10.63
+0.13 (1.26%)
Mar 20, 2026, 12:03 PM EDT - Market open

Revenue by Segment

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Development and Commercialization of Prophylactic Vaccines
361.30M348.09M---
Development and Commercialization of Prophylactic Vaccines Growth
3.80%----
Commercialized Products
--65.94M129.67M103.65M
Commercialized Products Growth
---49.15%25.11%11.59%
Vaccine Candidates
--31.60M-10.52M2.63M
Vaccine Candidates Growth
-----23.06%
Technologies and Services
--12.78M7.04M6.75M
Technologies and Services Growth
--81.57%4.24%-24.83%
Total
361.30M348.09M110.32M126.20M113.04M
Total Growth
3.80%215.52%-12.58%11.64%7.35%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
-23.80M40.34M36.41M63.70M42.46M
United States Growth
-10.78%-42.84%50.03%18.54%
Germany
68.53M726.00K7.06M10.35M7.97M
Germany Growth
9339.26%-89.72%-31.75%29.82%-
Canada
18.90M4.23M8.97M24.40M22.38M
Canada Growth
347.33%-52.86%-63.25%9.03%9.21%
France
46.61M1.00M734.00K--
France Growth
4560.80%36.24%---
Austria
21.79M9.34M3.33M2.67M4.96M
Austria Growth
133.30%180.26%24.93%-46.25%-
United Kingdom
181.13M2.71M1.85M8.59M8.15M
United Kingdom Growth
6591.13%46.56%-78.51%5.42%0.52%
Nordics
12.04M2.44M2.87M11.03M11.62M
Nordics Growth
394.38%-15.00%-74.01%-5.07%9.86%
Other Europe
18.74M2.08M1.33M4.96M8.25M
Other Europe Growth
803.13%55.55%-73.11%-39.87%-65.43%
Rest Of World
17.36M134.00K3.38M3.82M5.65M
Rest Of World Growth
12855.22%-96.04%-11.39%-32.37%-12.29%
Switzerland
----1.60M
Total
361.30M62.98M65.94M129.51M113.03M
Total Growth
473.64%-4.48%-49.09%14.58%7.35%
Source: S&P Global Market Intelligence.